Brief: Gossamer Bio Q1 EPS USD -0.19
07/05/2024 21:01
May 07 (Reuters) - Gossamer Bio Q1 operating income USD -41.959 million. * Q1 net income USD -41.928 million * Q1 basic EPS USD -0.19 * Q1 operating expenses USD 41.959 million
Recent news on Gossamer Bio
See all newsBrief: Gossamer Bio Submits New Drug Application To US FDA For Seralutinib For The Treatment Of Pulmonary Arterial Hypertension
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing